You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression

 

Online download statistics by month:

Online download statistics by month: March 2023 to September 2025

AbstractFullPdf
Mar 2023587613247
Apr 202327928070
May 202315015156
Jun 202311811839
Jul 2023888830
Aug 202311311318
Sep 2023899121
Oct 2023868632
Nov 202314914928
Dec 2023767740
Jan 2024909050
Feb 2024585835
Mar 2024898986
Apr 2024697156
May 2024818440
Jun 2024636450
Jul 2024676848
Aug 2024545728
Sep 2024838443
Oct 20245858154
Nov 2024828336
Dec 2024798034
Jan 2025707046
Feb 202512512531
Mar 2025585835
Apr 2025969667
May 202512212366
Jun 202517517639
Jul 2025110
Sep 2025110
Total325633021525